Allogeneic stimulation of naturally occurring CD4+CD25+ T cells induces strong regulatory capacity with increased donor-reactivity

Transplant Immunology

Volumn 17, Issue 4, 2007, Pages 237-242

  Coenen, Jeroen J A ^a   Koenen, Hans J P M ^a   Emmer, Peter M ^a   van Rijssen, Esther ^a   Hilbrands, Luuk B ^a   Joosten, Irma ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alloreactivity; Regulatory T cell; Rejection

Indexed keywords

ALLOGRAFT; ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SKIN TRANSPLANTATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGEN PRESENTATION; ANTIGENS, CD3; ANTIGENS, CD4; COCULTURE TECHNIQUES; DENDRITIC CELLS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; ISOANTIGENS; MICE; PHENOTYPE; T-LYMPHOCYTES, REGULATORY; TISSUE DONORS; TRANSPLANTATION TOLERANCE;

EID: 34247633481     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2007.01.004     Document Type: Article

References (30)

1. Lechler R.I., Sykes M., Thomson A.W., and Turka L.A. Organ transplantation - how much of the promise has been realized?. Nat Med 11 6 (2005) 605-613
2. Sakaguchi S. Regulatory T cells: key controllers of immunologic self-tolerance. Cell 101 5 (2000) 455-458
3. Zheng X.X., Sanchez-Fueyo A., Sho M., Domenig C., Sayegh M.H., and Strom T.B. Favorably tipping the balance between cytopathic and regulatory T cells to create transplantation tolerance. Immunity 19 4 (2003) 503-514
4. Walsh P.T., Taylor D.K., and Turka L.A. Tregs and transplantation tolerance. J Clin Invest 114 10 (2004) 1398-1403
5. Hara M., Kingsley CI., Niimi M., Read S., Turvey S.E., Bushell A.R., et al. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol 166 6 (2001) 3789-3796
6. Schenk S., Kish D.D., He C., El Sawy T., Chiffoleau E., Chen C., et al. Alloreactive T cell responses and acute rejection of single class II MHC-disparate heart allografts are under strict regulation by CD4+ CD25+ T cells. J Immunol 174 6 (2005) 3741-3748
7. Wood K.J., and Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 3 3 (2003) 199-210
8. Shevach E.M. CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2 6 (2002) 389-400
9. Schwartz R.H. Natural regulatory T cells and self-tolerance. Nat Immunol 6 4 (2005) 327-330
10. Fisson S., Djelti F., Trenado A., Billiard F., Liblau R., Klatzmann D., et al. Therapeutic potential of self-antigen-specific CD4(+)CD25(+) regulatory T cells selected in vitro from a polyclonal repertoire. Eur J Immunol (2006)
11. Yamazaki S., Patel M., Harper A., Bonito A., Fukuyama H., Pack M., et al. Effective expansion of alloantigen-specific Foxp3+ CD25+ CD4+ regulatory T cells by dendritic cells during the mixed leukocyte reaction. Proc Natl Acad Sci U S A 103 8 (2006) 2758-2763
12. Trenado A., Sudres M., Tang Q., Maury S., Charlotte F., Gregoire S., et al. Ex vivo-expanded CD4+CD25+ immunoregulatory T cells prevent graft-versus-host-disease by inhibiting activation/differentiation of pathogenic T cells. J Immunol 176 2 (2006) 1266-1273
13. Zheng X.X., Sanchez-Fueyo A., Domenig C., and Strom T.B. The balance of deletion and regulation in allograft tolerance. Immunol Rev 196 (2003) 75-84
14. Graca L., Le Moine A., Lin C.Y., Fairchild P.J., Cobbold S.P., and Waldmann H. Donor-specific transplantation tolerance: the paradoxical behavior of CD4+CD25+ T cells. Proc Natl Acad Sci U S A 101 27 (2004) 10122-10126
15. Hsieh C.S., Zheng Y., Liang Y., Fontenot J.D., and Rudensky A.Y. An intersection between the self-reactive regulatory and nonregulatory T cell receptor repertoires. Nat Immunol 7 4 (2006) 401-410
16. Sanchez-Fueyo A., Sandner S., Habicht A., Mariat C., Kenny J., Degauque N., et al. Specificity of CD4+CD25+ regulatory T cell function in alloimmunity. J Immunol 176 1 (2006) 329-334
17. Lutz M.B., Suri R.M., Niimi M., Ogilvie A.L., Kukutsch N.A., Rossner S., et al. Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo. Eur J Immunol 30 7 (2000) 1813-1822 [JID-1273201]
18. Cohen J.L., Trenado A., Vasey D., Klatzmann D., and Salomon B.L. CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host disease. J Exp Med 196 3 (2002) 401-406
19. Taylor P.A., Panoskaltsis-Mortari A., Swedin J.M., Lucas P.J., Gress R.E., Levine B.L., et al. L-Selectin(hi) but not the L-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection. Blood 104 12 (2004) 3804-3812
20. Koenen H.J., Fasse E., and Joosten I. CD27/CFSE-Based Ex Vivo Selection of Highly Suppressive Alloantigen-Specific Human Regulatory T Cells. J Immunol 174 12 (2005) 7573-7583
21. Larsen C.P., Morris P.J., and Austyn J.M. Migration of dendritic leukocytes from cardiac allografts into host spleens. A novel pathway for initiation of rejection. J Exp Med 171 1 (1990) 307-314
22. Zhai Y., Meng L., Gao F., Busuttil R.W., and Kupiec-Weglinski J.W. Allograft rejection by primed/memory CD8+ T cells is CD154 blockade resistant: therapeutic implications for sensitized transplant recipients. J Immunol 169 8 (2002) 4667-4673
23. Suchin E.J., Langmuir P.B., Palmer E., Sayegh M.H., Wells A.D., and Turka L.A. Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question. J Immunol 166 2 (2001) 973-981
24. Fisson S., Darrasse-Jeze G., Litvinova E., Septier F., Klatzmann D., Liblau R., et al. Continuous Activation of autoreactive CD4+ CD25+ regulatory T Cells in the steady state. J Exp Med 198 5 (2003) 737-746
25. Ruprecht C.R., Gattorno M., Ferlito F., Gregorio A., Martini A., Lanzavecchia A., et al. Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia. J Exp Med 201 11 (2005) 1793-1803
26. Tarbell K.V., Yamazaki S., Olson K., Toy P., and Steinman R.M. CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J Exp Med 199 11 (2004) 1467-1477
27. Tang Q., Henriksen K.J., Bi M., Finger E.B., Szot G., Ye J., et al. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med 199 11 (2004) 1455-1465
28. Ochando J.C., Yopp A.C., Yang Y., Garin A., Li Y., Boros P., et al. Lymph node occupancy is required for the peripheral development of alloantigen-specific Foxp3+ regulatory T cells. J Immunol 174 11 (2005) 6993-7005
29. Graca L., Cobbold S.P., and Waldmann H. Identification of regulatory T cells in tolerated allografts. J Exp Med 195 12 (2002) 1641-1646
30. Steger U., Kingsley CI., Karim M., Bushell A.R., and Wood K.J. CD25+CD4+ regulatory T cells develop in mice not only during spontaneous acceptance of liver allografts but also after acute allograft rejection. Transplantation 82 9 (2006) 1202-1209